4.6 Article

Retinopathy and Cognitive Impairment in Adults With CKD

Journal

AMERICAN JOURNAL OF KIDNEY DISEASES
Volume 61, Issue 2, Pages 219-227

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2012.10.006

Keywords

Chronic kidney disease; cognitive impairment; retinopathy

Funding

  1. National Institutes of Health (NIH) [U01 DK060980, U01 DK060902, U01 DK060963, U01 DK060984, U01 DK060990, U01 DK061021, U01 DK061022]
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [UL1 RR-024134, UL1 RR-025005, MO1 RR-16500, UL1 RR-024989, MO1 RR-000042, UL1 RR-024986, UL1 RR-029879, UL1 RR-024131]
  3. NIDDK grant [R01 DK069406]
  4. NIH [R01 DK74151]
  5. Vivian S. Lasko Research Fund
  6. Nina C. Mackall Trust, and Research to Prevent Blindness

Ask authors/readers for more resources

Background: Retinal microvascular abnormalities have been associated with cognitive impairment, possibly serving as a marker of cerebral small-vessel disease. This relationship has not been evaluated in persons with chronic kidney disease (CKD), a condition associated with increased risk of both retinal pathology and cognitive impairment. Study Design: Cross-sectional study. Setting & Participants: 588 participants 52 years or older with CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. Predictor: Retinopathy graded using the Early Treatment Diabetic Retinopathy Study severity scale and diameters of retinal vessels. Outcomes: Neuropsychological battery of 6 cognitive tests. Measurements: Logistic regression models were used to evaluate the association of retinopathy, individual retinopathy features, and retinal vessel diameters with cognitive impairment (<= 1 SD from the mean), and linear regression models were used to compare cognitive test scores across levels of retinopathy, adjusting for age, race, sex, education, and medical comorbid conditions. Results: The mean age of the cohort was 65.3 +/- 5.6 (SD) years, 51.9% were nonwhite, and 52.6% were men. The prevalence of retinopathy was 30.1%, and the prevalence of cognitive impairment was 14.3%. Compared with those without retinopathy, participants with retinopathy had an increased likelihood of cognitive impairment on executive function (35.1% vs 11.5%; OR, 3.4 [ 95% CI, 2.0-6.0]), attention (26.7% vs 7.3%; OR, 3.0 [ 95% CI, 1.8-4.9]), and naming (26.0% vs 10.0%; OR, 2.1 [ 95% CI, 1.2-3.4]) after multivariable adjustment. Increased level of retinopathy also was associated with lower cognitive performance on executive function and attention. Microaneurysms were associated with cognitive impairment on some domains, but there were no significant associations with other retinal measures after multivariable adjustment. Limitations: Unknown temporal relationship between retinopathy and impairment. Conclusions: In adults with CKD, retinopathy is associated with poor performance on several cognitive domains, including executive function and attention. Evaluation of retinal microvascular abnormalities may be a promising tool for identifying patients with CKD who are at increased risk of cognitive impairment. Am J Kidney Dis. 61(2): 219-227. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available